NeuroPace, Inc. – NASDAQ:NPCE
NeuroPace stock price today
$8.28
-2.39
-22.4%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 11 hours
NeuroPace stock price monthly change
+43.41%
month
NeuroPace stock price quarterly change
+43.41%
quarter
NeuroPace stock price yearly change
+6.06%
year
NeuroPace key metrics
Market Cap | 330.71M |
Enterprise value | 177.39M |
P/E | -2.28 |
EV/Sales | 3.89 |
EV/EBITDA | -4.85 |
Price/Sales | 2.50 |
Price/Book | 3.28 |
PEG ratio | -0.19 |
EPS | -1.19 |
Revenue | 69.07M |
EBITDA | -23.02M |
Income | -31.50M |
Revenue Q/Q | 25.23% |
Revenue Y/Y | 42.07% |
Profit margin | -103.43% |
Oper. margin | -89.62% |
Gross margin | 71.38% |
EBIT margin | -89.62% |
EBITDA margin | -33.34% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuroPace stock price history
NeuroPace stock forecast
NeuroPace financial statements
| Jun 2023 | 16.51M | -9.12M | -55.26% |
|---|---|---|---|
| Sep 2023 | 16.42M | -7.25M | -44.18% |
| Dec 2023 | 18.01M | -6.2M | -34.42% |
| Mar 2024 | 18.12M | -8.92M | -49.24% |
| Mar 2024 | 18.12M | -8.92M | -49.24% |
|---|---|---|---|
| Sep 2025 | 23.25M | -6.43M | -27.66% |
| Oct 2025 | 23.36M | -6.69M | -28.65% |
| Dec 2025 | 24.71M | -5.84M | -23.65% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 102232000 | 81.00M | 79.24% |
|---|---|---|---|
| Sep 2023 | 99300000 | 82.93M | 83.52% |
| Dec 2023 | 107651000 | 86.99M | 80.81% |
| Mar 2024 | 98853000 | 84.51M | 85.49% |
| Jun 2023 | -4.36M | 5.3M | 195K |
|---|---|---|---|
| Sep 2023 | -2.30M | 4.19M | -27K |
| Dec 2023 | -3.34M | 3.46M | 8.21M |
| Mar 2024 | -7.52M | 2.39M | 72K |
NeuroPace alternative data
| Aug 2023 | 163 |
|---|---|
| Sep 2023 | 169 |
| Oct 2023 | 169 |
| Nov 2023 | 169 |
| Dec 2023 | 169 |
| Jan 2024 | 169 |
| Feb 2024 | 169 |
| Mar 2024 | 171 |
| Apr 2024 | 171 |
| May 2024 | 171 |
| Jun 2024 | 181 |
| Jul 2024 | 181 |
NeuroPace other data
29.33%
-40.86%
of NPCE is owned by hedge funds
12
-10
7.21M
-10.14M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2023 | 0 | 8314 |
| Nov 2023 | 0 | 24097 |
| Dec 2023 | 0 | 30378 |
| Jan 2024 | 0 | 14013 |
| Feb 2024 | 0 | 18252 |
| Apr 2024 | 0 | 568426 |
| May 2024 | 0 | 29206 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 5 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 11 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of NeuroPace stock today?
One share of NeuroPace stock can currently be purchased for approximately $8.28.
-
When is NeuroPace's next earnings date?
Unfortunately, NeuroPace's (NPCE) next earnings date is currently unknown.
-
Does NeuroPace pay dividends?
No, NeuroPace does not pay dividends.
-
How much money does NeuroPace make?
NeuroPace has a market capitalization of 330.71M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 43.72% to 65.42M US dollars.
-
What is NeuroPace's stock symbol?
NeuroPace, Inc. is traded on the NASDAQ under the ticker symbol "NPCE".
-
What is NeuroPace's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of NeuroPace?
Shares of NeuroPace can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NeuroPace's key executives?
NeuroPace's management team includes the following people:
- Mr. Michael L. Favet Pres, Chief Executive Officer & Director(age: 55, pay: $658,230)
- Dr. Martha J. Morrell Chief Medical Officer(age: 68, pay: $480,180)
- Ms. Rebecca L. Kuhn Chief Financial Officer, Vice President of Fin. & Admin. and Assistant Sec.(age: 64, pay: $440,920)
-
How many employees does NeuroPace have?
As Jul 2024, NeuroPace employs 181 workers, which is 6% more then previous quarter.
-
When NeuroPace went public?
NeuroPace, Inc. is publicly traded company for more then 4 years since IPO on 22 Apr 2021.
-
What is NeuroPace's official website?
The official website for NeuroPace is neuropace.com.
-
Where are NeuroPace's headquarters?
NeuroPace is headquartered at 455 North Bernardo Avenue, Mountain View, CA.
-
How can i contact NeuroPace?
NeuroPace's mailing address is 455 North Bernardo Avenue, Mountain View, CA and company can be reached via phone at +65 02372700.
NeuroPace company profile:
NeuroPace, Inc.
neuropace.comExchange:
NASDAQ
Full time employees:
184
Industry:
Medical - Devices
Sector:
Healthcare
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
455 North Bernardo Avenue
Mountain View, CA 94043
Mountain View, CA 94043
CIK: 0001528287
ISIN: US6412881053
CUSIP: 641288105
